(Total Views: 499)
Posted On: 06/18/2021 10:07:26 AM
Post# of 22462
Crunch,
I included the following quote from the FDA contained in their letter. It points to directly of the lack of submission of the required 510-K application to manufacture, sell and distribute a medical product in the United States.
Regards
Sunny:>
))
I included the following quote from the FDA contained in their letter. It points to directly of the lack of submission of the required 510-K application to manufacture, sell and distribute a medical product in the United States.
Quote:
To date, the FDA has not received reports of injuries or death associated with use of the Innova SARS-CoV-2 Antigen Rapid Qualitative Test.
Regards
Sunny:>
)) 
(1)
(0)Scroll down for more posts ▼
